Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. - Wikidata - awgldk - TriplyDB

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma.

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma.

http://www.wikidata.org/entity/Q39424270

about

microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment The challenge of developmental therapeutics for adrenocortical carcinoma A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.Emerging therapy for adrenocortical carcinoma.Adrenocortical carcinoma: the management of metastatic disease.Current and emerging therapeutic options in adrenocortical cancer treatment.Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review Adrenal incidentalomas in cancer patients are not always "innocent": a case report and review of the literature Novel targeted therapies in adrenocortical carcinoma.The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.Targeted therapy with kinase inhibitors in aggressive endocrine tumors.Management of adrenal cancer: a 2013 update.Metronomics: towards personalized chemotherapy?Diagnosis, treatment and outcome of adrenocortical cancer.Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma.Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide.Clinical Case of Metastatic Adrenocortical Carcinoma With Unusual Evolution: Review the Literature Everolimus therapy for progressive adrenocortical cancer.STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.Development of new preclinical models to advance adrenocortical carcinoma research.Adrenocortical carcinoma Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial

P2860

Q26772746-55B96C77-53D5-4A72-9156-E8CF27AEEEE7 Q26801839-1321BCFA-5B7A-4665-9329-8D953A6382C7 Q28072970-5AD8C899-1AF5-4DEE-BDCD-4626B049D67F Q34017912-2767B59C-5970-4C65-9DCF-44898B285135 Q34173001-FB9330E8-E802-4024-B9F8-88BB7F9AE3E0 Q34431264-CAA6229C-F049-48FD-992E-9399F274C631 Q35018399-16373A07-6088-409E-A1BC-D8F989BC1D8A Q36081865-EF48FA47-67F6-44F5-937D-DF2C6CD83121 Q36183873-FF91FF92-1035-4182-B838-D595CF8D3529 Q36270115-8D542A73-1FB5-4BDC-B69E-DFA09D2CC75B Q36804969-1D47C4BF-8EF1-462D-9FCB-A8DABB0F44C0 Q37233378-1F0C1606-0C9E-414E-9E8C-75E9976DBEC7 Q37681171-0DF6A89A-990E-4F78-9964-FF85F415E2FD Q38107011-D81E5D41-B40D-4A31-BD92-09DD9DC2B212 Q38181425-AB21F2B7-C85E-4483-BCE2-86C2DB1D2561 Q38218923-7168301B-0151-43C1-9F1D-F4453480131B Q38358503-C1A5AA21-5DFD-435F-8DCC-D97685D058F0 Q38545507-736D67A6-F557-4ED7-9CA8-462B0CC1951D Q38640345-3279F86C-9502-4B8B-B1D6-73F0B2F68161 Q38686201-0CE674AB-90D7-4C66-BA5B-266200DB40EE Q40862337-06CDE2A2-4C15-4263-A8AE-14670DB3D4D2 Q41863971-825E7A3B-4AD0-4DA2-A951-70720E263E05 Q43478917-C8B7EF3B-8154-4DE1-9176-B0B175F9CCC8 Q47321196-3857F860-0181-46B8-8922-2161F125095B Q49676347-90BA531F-492E-42DA-8687-BB4296886DBE Q49681867-8B1DD016-0138-4202-9D53-1BCCF8BA4CCE Q57645859-DD2A0713-A0BC-4AF4-9C07-02B64297B9A3 Q57803796-3C6EC649-E6E5-42D3-AFAB-E5904184142F

P2860

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma.

http://www.wikidata.org/entity/Q39424270

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Phase II study of weekly pacli ...... with adrenocortical carcinoma.

@en

Phase II study of weekly pacli ...... with adrenocortical carcinoma.

@nl

type

label

Phase II study of weekly pacli ...... with adrenocortical carcinoma.

@en

Phase II study of weekly pacli ...... with adrenocortical carcinoma.

@nl

prefLabel

Phase II study of weekly pacli ...... with adrenocortical carcinoma.

@en

Phase II study of weekly pacli ...... with adrenocortical carcinoma.

@nl

P1433

Q39424270-E978303A-13ED-4D88-B62B-B6CE3FEEC7D8

P1476

Q39424270-7B036C49-E43F-4DF4-A95C-16AE2BCB21FC

P2093

Q39424270-11D92EC3-FA83-4526-8185-7A8B7F0D2CBB

Q39424270-1BCF57B2-2743-49EB-9839-53D2C4BB0368

Q39424270-3A99F01C-863B-413A-A904-C7DDEFA0C89D

Q39424270-53C6A536-4EF6-4051-AEF4-18595A0F6B63

Q39424270-6788C2A1-E45B-48A5-BE39-F0171923958A

Q39424270-719A7101-9D0F-40B6-A5F7-F5C54E0CA3BC

Q39424270-7537D1E5-83DA-4637-A04C-3A54E8F6EA06

Q39424270-982D8EE6-A495-408A-AAA3-088C90B848D0

Q39424270-9B98C5B5-1B43-4E80-B955-AE38CAA8C5D3

Q39424270-B558AEAE-C80B-47C5-A89C-1C3D1D777831

P304

Q39424270-88FFBE1E-9B08-42FC-83A6-C99F8F8AB4A2

P31

Q39424270-F6887462-582B-481F-82E8-83CF61EDB461

P356

Q39424270-FB43EBC4-D3C5-4533-A334-7EE5C4F39734

P433

Q39424270-22B6E3DD-0356-49B5-86ED-37F0F34617D1

P478

Q39424270-E597BE1A-8FD7-423C-9126-219268418B3B

P50

Q39424270-1E11DD6A-DFB2-4B6C-A108-B4055F9F5D7C

Q39424270-535CBF7C-7E9C-48FC-94DF-9C80CE1DE85B

Q39424270-54A6F260-F74E-42BB-86A9-8DD46BEB079F

P577

Q39424270-028D9334-7C8D-4B25-B087-55E23D322C78

P698

Q39424270-C8B4AD87-BA49-4268-AD9C-50B55DBA12F2

P356

P1433

European Journal of Endocrinology

P1476

Phase II study of weekly pacli ...... with adrenocortical carcinoma.

@en

P2093

Adriano Massimiliano Priola

http://www.w3.org/2001/XMLSchema#string

Alfredo Berruti

http://www.w3.org/2001/XMLSchema#string

Anna Ferrero

http://www.w3.org/2001/XMLSchema#string

Arianna Ardito

http://www.w3.org/2001/XMLSchema#string

Eric Baudin

http://www.w3.org/2001/XMLSchema#string

Fulvia Daffara

http://www.w3.org/2001/XMLSchema#string

Marco Volante

http://www.w3.org/2001/XMLSchema#string

Mauro Papotti

http://www.w3.org/2001/XMLSchema#string

Paola Perotti

http://www.w3.org/2001/XMLSchema#string

Paola Sperone

http://www.w3.org/2001/XMLSchema#string

P304

451-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/EJE-11-0918

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Terzolo

Daniele Generali

Antonina Germano

P577

2011-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22189997

http://www.w3.org/2001/XMLSchema#string